Search Constraints
« Previous |
31 - 40 of 81
|
Next »
Search Results
Select an image to start the slideshow
Preclinical development of a treatment for systemic lupus erythematosus
1 of 10
The design and synthesis of novel epigenetic modulators
2 of 10
Design and synthesis of dimethylisoxazole quinolines as BET inhibitors
3 of 10
The development of chemo- and regioselective reactions of boron systems
4 of 10
New chemical approaches for the development of targeted protein degradation
5 of 10
Targeted protein degradation as a new approach to drug discovery
6 of 10
The design and synthesis of probe molecules to validate the inhibition of epigenetic mechanisms for phenotypic responses
7 of 10
The synthesis and optimisation of toll-like receptor agonists as potential immunomodulatory agents
8 of 10
The design, synthesis and optimisation of phosphoinositide-3-kinase (PI3K) inhibitors as potential anti-inflammatory agents
9 of 10
The design, synthesis and optimisation of calcium release-activated calcium (CRAC) channel inhibitors and mitochondrial permeability transition pore (mPTP) modulators, using phenotypic screening
10 of 10